Related references
Note: Only part of the references are listed.Prolonged coenzyme Q10 treatment in Down syndrome patients, effect on DNA oxidation
Luca Tiano et al.
NEUROBIOLOGY OF AGING (2012)
Evaluation of urinary biomarkers of oxidative/nitrosative stress in adolescents and adults with Down syndrome
Carlos Campos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Elevated intracellular calcium causes distinct mitochondrial remodelling and calcineurin-dependent fission in astrocytes
Andrew R. Tan et al.
CELL CALCIUM (2011)
The role of DYRK1A in neurodegenerative diseases
Jerzy Wegiel et al.
FEBS JOURNAL (2011)
The role of mitochondrial DNA damage in the citotoxicity of reactive oxygen species
R. A. P. Costa et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2011)
Calcium Binding and Transport by Coenzyme Q
Ivan Bogeski et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Advances in metal-induced oxidative stress and human disease
Klaudia Jomova et al.
TOXICOLOGY (2011)
Inhibition of Drp1-dependent mitochondrial fragmentation and apoptosis by a polypeptide antagonist of calcineurin
G. M. Cereghetti et al.
CELL DEATH AND DIFFERENTIATION (2010)
Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders
M. Mancuso et al.
CURRENT DRUG TARGETS (2010)
Mitochondrial medicine for neurodegenerative diseases
Heng Du et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Clinical aspects of coenzyme Q(10): An update
Gian Paolo Littarru et al.
NUTRITION (2010)
A Role for Thrombospondin-1 Deficits in Astrocyte-Mediated Spine and Synaptic Pathology in Down's Syndrome
Octavio Garcia et al.
PLOS ONE (2010)
Communication breaks-Down: From neurodevelopment defects to cognitive disabilities in Down syndrome
Andrea Contestabile et al.
PROGRESS IN NEUROBIOLOGY (2010)
Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1
Joongkyu Park et al.
BMB REPORTS (2009)
Function and regulation of Dyrk1A: towards understanding Down syndrome
Joongkyu Park et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Down syndrome critical region 1 enhances the proteolytic cleavage of calcineurin
Ji-Eun Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
DELAYED ONTOGENESIS IN HUMAN TRISOMY SYNDROMES1
BERTIL HALL
HEREDITAS (2009)
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Xinglong Wang et al.
JOURNAL OF NEUROSCIENCE (2009)
Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease
M. Flint Beal
PARKINSONISM & RELATED DISORDERS (2009)
Mitochondrial Approaches for Neuroprotection
Rajnish K. Chaturvedi et al.
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
Biomarkers of oxidative damage to DNA and repair
Steffen Loft et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Coenzyme Q(10) and oxidative imbalance in Down syndrome: Biochemical and clinical aspects
L. Tiano et al.
BIOFACTORS (2008)
Mitochondrial dysfunction in mouse trisomy 16 brain
L. L. Bambrick et al.
BRAIN RESEARCH (2008)
Disease-specific induced pluripotent stem cells
In-Hyun Park et al.
CELL (2008)
Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy
J. M. Cooper et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Coenzyme Q10 attenuates β-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation
Xifei Yang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Mitochondrial alterations in Parkinson's disease: new clues
Miquel Vila et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Short-term effects of coenzyme Q10 in progressive supranuclear palsy:: A randomized, placebo-controlled trial
Maria Stamelou et al.
MOVEMENT DISORDERS (2008)
Mental retardation in Down syndrome: From gene dosage imbalance to molecular and cellular mechanisms
Mohammed Rachidi et al.
NEUROSCIENCE RESEARCH (2007)
Coenzyme Q10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21
Michael V. Miles et al.
PEDIATRIC NEUROLOGY (2007)
Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy
Anna Conti et al.
BMC GENOMICS (2007)
Down syndrome gene dosage imbalance on cerebellum development
Randal X. Moldrich et al.
PROGRESS IN NEUROBIOLOGY (2007)
Friedreich's ataxia:: Coenzyme Q10 and vitamin E therapy
J. M. Cooper et al.
MITOCHONDRION (2007)
Oxidative stress:: A bridge between Down's syndrome and Alzheimer's disease
Marianna Zana et al.
NEUROBIOLOGY OF AGING (2007)
Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome
Erika Roat et al.
FEBS LETTERS (2007)
Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine
Andrew D. Hershey et al.
HEADACHE (2007)
Multiple evidence for an early age pro-oxidant state in Down Syndrome patients
Federico V. Pallardo et al.
BIOGERONTOLOGY (2006)
Age-dependent oxidative stress-induced DNA damage in Down's lymphocytes
Marianna Zana et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Mitochondrial DNA maintenance and bioenergetics
JA Stuart et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS
KL Ferrante et al.
NEUROLOGY (2005)
Oxidative stress and hematologic and biochemical parameters in individuals with Down syndrome
ME Garcez et al.
MAYO CLINIC PROCEEDINGS (2005)
Efficacy of coenzyme Q10 in migraine prophylaxis:: A randomized controlled trial
PS Sándor et al.
NEUROLOGY (2005)
Assessment of DNA damage in Down Syndrome patients by means of a new, optimised single cell gel electrophoresis technique
Luca Tiano et al.
BIOFACTORS (2005)
Uric acid and allantoin levels in Down syndrome:: antioxidant and oxidative stress mechanisms?
I Zitnanová et al.
CLINICA CHIMICA ACTA (2004)
Chromosome 21 and Down syndrome: From genomics to pathophysiology
SE Antonarakis et al.
NATURE REVIEWS GENETICS (2004)
Measuring the effects of therapy in Parkinson disease
CW Shults et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Coenzyme Q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property
L Papucci et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The role of mitochondrial oxidative stress in aging
J Sastre et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Primary coenzyme Q(10) deficiency and the brain
A Naini et al.
BIOFACTORS (2003)
Overview on coenzyme Q(10) as adjunctive therapy in chronic heart failure. Rationale, design and end-points of Q-symbio - A multinational trial
SA Mortensen
BIOFACTORS (2003)
Effects of coenzyme Q10 in early Parkinson disease -: Evidence of slowing of the functional decline
CW Shults et al.
ARCHIVES OF NEUROLOGY (2002)
Mitochondrial dysfunction and Down's syndrome
S Arbuzova et al.
BIOESSAYS (2002)
Evidence for increased mitochondrial superoxide production in Down syndrome
G Capone et al.
LIFE SCIENCES (2002)
Altered metabolism of the amyloid β precursor protein is associated with mitochondrial dysfunction in Down's syndrome
J Busciglio et al.
NEURON (2002)
Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients
J Muchová et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Chromosome 21: from sequence to applications
SE Antonarakis
CURRENT OPINION IN GENETICS & DEVELOPMENT (2001)
Down syndrome: Advances in molecular biology and the neurosciences
GT Capone
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS (2001)
Increased mitochondrial superoxide generation in neurons from trisomy 16 mice: a model of Down's syndrome
S Schuchmann et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Share Paper
